•
Jun 30, 2023

Akoya Q2 2023 Earnings Report

Akoya reported record revenue and the milestone of the 1,000th publication featuring Akoya platforms in the second quarter of 2023.

Key Takeaways

Akoya Biosciences reported a strong financial performance in Q2 2023, achieving record revenue of $23.5 million, a 31% increase year-over-year. The company highlighted its leading position in spatial biology and its focus on moving towards profitability.

Total revenue reached $23.5 million, a 31% increase compared to the prior year period.

Product revenue (instruments, reagents, and software) increased by 20% to $17.1 million.

Service and other revenue grew significantly by 73% to $6.4 million.

Gross profit was $12.1 million with a gross profit margin of 51.5%.

Total Revenue
$23.5M
Previous year: $17.9M
+31.4%
EPS
-$0.51
Previous year: -$0.47
+8.5%
Gross Profit
$12.1M
Previous year: $10.3M
+17.2%
Cash and Equivalents
$93.3M
Previous year: $46.9M
+99.1%
Free Cash Flow
-$13.2M
Previous year: -$15M
-11.5%
Total Assets
$189M
Previous year: $184M
+2.5%

Akoya

Akoya

Akoya Revenue by Segment

Forward Guidance

The company continues to expect full year 2023 revenue in the range of $95-98 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income